Jefferies Sticks to Its Buy Rating for InnoCare Pharma Ltd. (9969)
TipRanksOct 27 08:17 ET
InnoCare Pharma Ltd. (9969) Gets a Buy From Jefferies
TipRanksSep 4 08:22 ET
UBS Adjusts InnoCare Pharma’s Price Target to HK$16.20 From HK$17.70, Keeps at Buy
MT NewswiresAug 24, 2022 04:21 ET
No Data